Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse T Davidson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Transplantation|August 22, 2023
The impact of a dedicated operating room team on robotic transplant program growth and fellowship trainingAngela L Hill, Meranda D Scherer, Amen Kiani, et al.
Journal of Surgical Oncology|December 27, 2018
Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutionsJesse T Davidson, Linda X Jin, Bradley Krasnick, et al.
American Journal of Surgery|October 17, 2022
A novel assessment model for teaching robot-assisted living donor nephrectomy in abdominal transplant surgery fellowshipJesse T Davidson, Julie M Clanahan, Neeta Vachharajani, et al.
Journal of Robotic Surgery|June 27, 2024
Robotic performance metrics model fellow proficiency in living donor nephrectomyJesse T Davidson, Julie M Clanahan, Amen Kiani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 6, 2011
Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugsMartin J Hicks, Bishnu P De, Jonathan B Rosenberg, et al.
Nature|August 14, 2020
cDC1 prime and are licensed by CD4<sup>+</sup> T cells to induce anti-tumour immunityStephen T Ferris, Vivek Durai, Renee Wu, et al.
Science (New York, N.Y.)|November 10, 2018
WDFY4 is required for cross-presentation in response to viral and tumor antigensDerek J Theisen, Jesse T Davidson, Carlos G Briseño, et al.
Nature Immunology|August 14, 2019
Cryptic activation of an Irf8 enhancer governs cDC1 fate specificationVivek Durai, Prachi Bagadia, Jeffrey M Granja, et al.
Journal of Surgical Oncology|December 29, 2017
Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortiumBradley A Krasnick, Linda X Jin, Jesse T Davidson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 25, 2017
Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortiumGregory V Schimizzi, Linda X Jin, Jesse T Davidson, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Transplantation|August 22, 2023
The impact of a dedicated operating room team on robotic transplant program growth and fellowship trainingAngela L Hill, Meranda D Scherer, Amen Kiani, et al.
Journal of Surgical Oncology|December 27, 2018
Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutionsJesse T Davidson, Linda X Jin, Bradley Krasnick, et al.
American Journal of Surgery|October 17, 2022
A novel assessment model for teaching robot-assisted living donor nephrectomy in abdominal transplant surgery fellowshipJesse T Davidson, Julie M Clanahan, Neeta Vachharajani, et al.
Journal of Robotic Surgery|June 27, 2024
Robotic performance metrics model fellow proficiency in living donor nephrectomyJesse T Davidson, Julie M Clanahan, Amen Kiani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 6, 2011
Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugsMartin J Hicks, Bishnu P De, Jonathan B Rosenberg, et al.
Nature|August 14, 2020
cDC1 prime and are licensed by CD4<sup>+</sup> T cells to induce anti-tumour immunityStephen T Ferris, Vivek Durai, Renee Wu, et al.
Science (New York, N.Y.)|November 10, 2018
WDFY4 is required for cross-presentation in response to viral and tumor antigensDerek J Theisen, Jesse T Davidson, Carlos G Briseño, et al.
Nature Immunology|August 14, 2019
Cryptic activation of an Irf8 enhancer governs cDC1 fate specificationVivek Durai, Prachi Bagadia, Jeffrey M Granja, et al.
Journal of Surgical Oncology|December 29, 2017
Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortiumBradley A Krasnick, Linda X Jin, Jesse T Davidson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 25, 2017
Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortiumGregory V Schimizzi, Linda X Jin, Jesse T Davidson, et al.
Pageof 3